Sarah Reinhardt, MPH, RD and Ricardo J. Salvador, PhD, MS
Clinicians should contribute to healthful, equitable, sustainable food procurement initiatives consistent with their institutions' health-promotion missions.
AMA J Ethics. 2018;20(10):E974-978. doi:
10.1001/amajethics.2018.974.
Annette Hanson, MD, Ron Pies, MD, and Mark Komrad, MD
Authors respond to “How Should Physicians Care for Dying Patients with Amyotrophic Lateral Sclerosis?” by arguing that patients’ motives for accessing death with dignity laws should be thoroughly explored and that temporarily limiting patient autonomy can promote well-being at the end of life.
AMA J Ethics. 2018;20(11):E1107-1109. doi:
10.1001/amajethics.2018.1107.
Alexander Craig, MPhil and Elizabeth Dzeng, MD, PhD, MPH
Responding to “Added Points of Concern about Caring for Dying Patients,” authors argue that physicians’ refusal to prescribe lethal drugs in accordance with states’ death with dignity laws could damage patient-physician relationships and harm patients.
AMA J Ethics. 2018;20(11):E1110-1112. doi:
10.1001/amajethics.2018.1110.
Ann Claire Greiner, MCP and Anita Duhl Glicken, MSW
Five lessons from the patient-centered medical home could help motivate infrastructure investment, care innovation, and payment reforms critical to achieving equity.
AMA J Ethics. 2022;24(1):E64-72. doi:
10.1001/amajethics.2022.64.
Streamlining US health care business has raised unique privacy concerns. Bills and explanations of benefits contain protected health information that could be disclosed to someone other than the patient.
AMA J Ethics. 2016;18(3):279-287. doi:
10.1001/journalofethics.2016.18.3.pfor4-1603.